A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.

A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research effort has uncovered how a highly aggressive type of pancreatic cancer is ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

The biotech will now take atebimetinib to mid- and late-stage trials in NSCLC and pancreatic cancer, respectively.

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...

SEATTLE — Cancer fighters of all ages are gathering to strut their stuff for an organization that's been supporting patients and families for decades. The fashion show "Surviving with Style" is set ...

Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer treatments, according to a study led by Dr. Martin Taylor at the Warren Alpert ...